Search

everythinglearnresearchcommunity

for

Search:↓

CCT128930 is a promising new drug that effectively targets and inhibits a cancer-related protein, showing potential for cancer treatment.

A 17-year-old boy with Temporal Triangular Alopecia successfully grew new hair after a hair restoration surgery using follicular unit transplantation.

TAGX-0003 protected hair follicles and reversed alopecia areata in a mouse model.

Alopecia areata involves specific immune cells, offering potential treatment targets.

Extracellular ATP is crucial for plant root growth and signaling.

Antibody drug conjugates show promise in targeting cancer cells while reducing harm to healthy cells.

Ritlecitinib significantly improves scalp hair regrowth in alopecia areata patients over time.

Activating Tgr5 may help treat hair loss and bone loss.

Alopecia areata is a hair loss disease caused by complex immune reactions, and new targeted treatments show promise.

Baricitinib maintains significant hair regrowth in severe alopecia areata over three years.

PTEN helps control the number and health of skin stem cells by working with the protein BMAL1.

Rosemary may help treat various skin conditions due to its antioxidant and anti-inflammatory properties.

Iron deficiency worsens inflammatory skin diseases by disrupting iron balance and increasing inflammation.

Targeting androgen receptor signaling may improve acute myeloid leukemia treatment.

Baricitinib stops hair loss and promotes regrowth in alopecia areata.

A deficiency in the TTC7A gene causes immune problems, gut issues, and hair loss.

Baricitinib shows promise for severe alopecia areata but isn't a cure and has side effects.

Tofacitinib effectively regrows hair in alopecia areata patients, especially in younger individuals, with manageable side effects.

Alopecia areata involves immune system issues and specific cell types that disrupt hair growth, leading to hair loss.

LC-OCT is a promising tool for diagnosing and monitoring Alopecia areata.

The study concludes that Traction Alopecia is often overlooked in women and children of color, and better recognition and follow-up care are needed.

Baricitinib is a promising treatment for alopecia areata.

Bexarotene 1% topical gel helped some patients with alopecia areata regrow hair.

Pertussis toxin may contribute to hair loss in alopecia areata.

Cryotherapy with precise temperature control is a promising treatment for alopecia areata.

Minoxidil and ATRA together boost hair growth more effectively than minoxidil alone.

INTASYL is a promising, adaptable RNAi technology for treating skin cancers.

Baricitinib helps regrow hair and improves quality of life and mental health in severe alopecia areata patients.

Telitacicept effectively improved hair regrowth in a woman with lupus and alopecia.

JAK inhibitors may help treat alopecia areata by reversing hair loss.